Familial breast cancer
RAD51B in Familial Breast Cancer.
18
Variation in the RAD51 gene and familial breast cancer
7
The pathology of familial breast cancer: Immunohistochemistry and molecular analysis
5
Low frequency of E cadherinalterations in familial breast cancer
9
Immunoprofile from tissue microarrays to stratify familial breast cancer patients
15
Expanding the genetic basis of copy number variation in familial breast cancer
10
Mutation analysis of FANCD2, BRIP1/BACH1, LMO4 and SFN in familial breast cancer
12
The clinicopathological and MRI features of patients with BRCA1/2 mutations in familial breast cancer
11
Gene-expression patterns in peripheral blood classify familial breast cancer susceptibility
10
Relational distressed and maternal absence: Young women's lived experience of familial breast cancer
33
The pathology of familial breast cancer: The pathology of familial breast cancer How do the functions of BRCA1 and BRCA2 relate to breast tumour pathology?
7
The pathology of familial breast cancer: Morphological aspects
5
Familial Breast Cancer Referrals and Risk Management
20
BRIP1 loss of function mutations confer high risk for familial ovarian cancer, but not familial breast cancer
6
Analysis of cancer risk and BRCA1 and BRCA2mutation prevalence in the kConFab familial breast cancer resource
15
Prevalence of PALB2 mutations in Australian familial breast cancer cases and controls
11
A constant risk for familial breast cancer? A population based family study
7
Prevalance of BRCA1 and BRCA2 mutations in familial breast cancer patients in Lebanon
7
Next-generation sequencing in familial breast cancer patients from Lebanon
12
Comparison of BRCAx tumors with BRCA1 , BRCA2 carriers and non familial breast cancer
6